60
Participants
Start Date
September 21, 2023
Primary Completion Date
April 12, 2026
Study Completion Date
April 12, 2026
BMS-986326
Specified dose on specified days
Placebo for BMS-986326
Specified dose on specified days
RECRUITING
Clinica Adventista Belgrano, CABA
ACTIVE_NOT_RECRUITING
Local Institution - 0072, Sofia
RECRUITING
Hospital Universitario Austral, Pilar
WITHDRAWN
Columbia University Irving Medical Center, New York
RECRUITING
Charité Research Organisation, Berlin
RECRUITING
ARENSIA Exploratory Medicine, Bucharest
RECRUITING
Hospital Universitario Reina Sofia, Córdoba
RECRUITING
CHUAC-Complejo Hospitalario Universitario A Coruña, A Coruña
RECRUITING
Altoona Center For Clinical Research, Duncansville
WITHDRAWN
North Georgia Rheumatology, Lawrenceville
WITHDRAWN
Local Institution - 0077, Chihuahua City
RECRUITING
Clinical Research of West Florida, Tampa
RECRUITING
Clinical Research of West Florida, Inc. (Clearwater), Clearwater
RECRUITING
Skin Sciences, Louisville
WITHDRAWN
Allen Arthritis, Allen
WITHDRAWN
Metroplex Clinical Research Center, Dallas
COMPLETED
Local Institution - 0062, Las Vegas
COMPLETED
Local Institution - 0048, San Diego
RECRUITING
Arthritis Northwest, PLLC, Spokane
RECRUITING
ARENSIA Exploratory Medicine, Cluj-Napoca
RECRUITING
Städtisches Klinikum Dessau, Dessau
RECRUITING
Universitaetsklinikum Carl Gustav Carus Dresden, Dresden
WITHDRAWN
Local Institution - 0073, Cuauhtémoc, Ciudad de México
WITHDRAWN
Local Institution - 0068, Mexico City
COMPLETED
Local Institution - 0051, Leiden
RECRUITING
Klinika Ambroziak Dermatologia, Warsaw
RECRUITING
Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY